Abstract Number: 1103 • 2013 ACR/ARHP Annual Meeting
Brain Derived Neurotrophic Factor Is Elevated In Patients With Rheumatoid Arthritis and Secondary Fibromyalgia
Background/Purpose: Secondary Fibromyalgia is seen in 15% of patients with rheumatoid arthritis (RA). Neurotrophins are elevated in patients with active arthritis and BDNF is elevated…Abstract Number: 1092 • 2013 ACR/ARHP Annual Meeting
Low Dose Naltrexone In The Treatment Of Fibromyalgia
Background/Purpose: Fibromyalgia is a chronic pain disorder characterized by diffuse musculoskeletal pain, fatigue, sleepdisturbance and cognitive impairment. A significant number of fibromyalgia patients do not…Abstract Number: 1093 • 2013 ACR/ARHP Annual Meeting
SPA Therapy In The Treatment Of Chronic Shoulder PAIN Due To Rotator Cuff Tendinopathy: Rotatherm, A Large Randomized Multicentre Trial
Background/Purpose: To determine whether spa therapy has a beneficial effect on pain and disability in the management of shoulder pain due to chronic rotator cuff…Abstract Number: 1094 • 2013 ACR/ARHP Annual Meeting
Hyperbaric Oxygen Ameliorates Fibromyalgia Symptoms and Functional Impairment – A Randomized Prospective Trial
Background/Purpose: Fibromyalgia Syndrome (FMS), considered to represent a prototype of central nervous system sensitization, is a common condition characterized by chronic widespread pain and diffuse…Abstract Number: 1095 • 2013 ACR/ARHP Annual Meeting
Pooled Safety Data From Randomized, Controlled Trials Of Diclofenac Sodium Topical Gel 1% In Subjects With Acute Pain
Background/Purpose: Diclofenac sodium topical gel (DSG) 1% is clinically proven to be effective and well-tolerated for treatment of osteoarthritis pain and could be appropriate to…Abstract Number: 1096 • 2013 ACR/ARHP Annual Meeting
Is Vitamin D Deficiency a Risk Factor For The Development Of Statin Induced Myalgia, In Patients Treated With Statin?
Background/Purpose: Vitamin D deficiency has become pandemic in the industrializing societies. Recently, the role of vitamin D deficiency in the development of statin myopathy has…Abstract Number: 1097 • 2013 ACR/ARHP Annual Meeting
A Potential Use Of NeurotropinTM, a Novel Neuro-Modulating Medication, For The Treatment Of Chronic Pain and Fibromyalgia
Background/Purpose: To date, no established treatment for chronic pain including fibromyalgia has been specified in Japan. Neurotropin, a non-protein extract isolated from the inflamed cutaneous…Abstract Number: 1098 • 2013 ACR/ARHP Annual Meeting
Safety and Efficacy Of Influenza Vaccination In Patients Suffering From Fibromyalgia
Background/Purpose: Fibromyalgia syndrome (FMS) is considered to result from exposure of a genetically susceptible individual to various "triggers" including physical trauma, stress etc. Viral infections…Abstract Number: 1099 • 2013 ACR/ARHP Annual Meeting
IgG Autoantibodies Against p29ING4 In Early-Stage Type I Complex Regional Pain Syndrome (CRPS) and In Other Inflammatory Diseases Involving The Joints
Background/Purpose: Complex regional pain syndrome (CRPS, a.k.a. RSD) usually occurs after limb injury, especially fractures of the distal radius and elective hand surgery. Recent research…Abstract Number: 1100 • 2013 ACR/ARHP Annual Meeting
Relationship Between Body Mass Index, Fat Mass and Muscle Mass Withmusculoskeletal Pain In Community Residents
Background/Purpose: The association between parameters related to obesity likefat mass,fat/muscle mass ratio and metabolic syndrome andmusculoskeletal pain has scarcily been assessed. The objective of thepresent…Abstract Number: 1102 • 2013 ACR/ARHP Annual Meeting
The Correlation Among Macromastia, Spinal Pain, Thoracic Kyphosis and Fall Risk
Background/Purpose: Large breasts are commonly associated with musculoskeletal symptoms such as neck, shoulder, and back pain, as well as stiff neck, painful brasserie strap grooving,…Abstract Number: 1104 • 2013 ACR/ARHP Annual Meeting
Quality Of Life and Burden Of Ehlers-Danlos Syndrome (EDS) Type III
Background/Purpose: The Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of inherited connective tissue disorders. Hypermobility type EDS is the most common type…Abstract Number: 1105 • 2013 ACR/ARHP Annual Meeting
New and Not Improved? The Efficacy Of FMS Medications
Background/Purpose: A wide variety of medications are used to treat FMS, with an equally wide variety of opinions about their efficacy. We asked FMS…Abstract Number: 1106 • 2013 ACR/ARHP Annual Meeting
Effectiveness Of Interdisciplinary Program For Fibromyalgia
Background/Purpose: Fibromyalgia (FM) affects 5 million Americans, and the prevalence is estimated to be 2- 6 percent in the general population. The symptoms associated with…Abstract Number: 1107 • 2013 ACR/ARHP Annual Meeting
A Randomized Trial Of a Physical Self-Management Program For Fibromyalgia Syndrome
Background/Purpose: Fibromyalgia syndrome (FMS) is a painful disorder that interferes directly in the functional capacity and quality of life. Treatment advocates interventions in the physical,…